Enhanced antitumor activity of vitamin C via p53 in cancer cells.
暂无分享,去创建一个
Young Yang | D. Jin | Youngsoo Han | Jinsun Kim | J. Lim | Young-Sook Kang | Jong-Seok Lim | Young-Sook Kang | Soonduck Lee | Sam-Il Jung | Jinsun Kim | Soon-Duck Lee | Boogi Chang | Dong-Hoon Jin | Sam-Il Jung | Mee-Young Park | Youngsoo Han | Young Yang | Keun Il Kim | Myeong-Sok Lee | Myeong-Sok Lee | M. Park | Keun Il Kim | Boogi Chang
[1] C. Knudson,et al. Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer , 2010, Clinical Cancer Research.
[2] Y. Sekido,et al. High dose of ascorbic acid induces cell death in mesothelioma cells. , 2010, Biochemical and biophysical research communications.
[3] C. Glorieux,et al. Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress. , 2011, Anti-cancer agents in medicinal chemistry.
[4] W. Gu,et al. New insights into p53 activation , 2010, Cell Research.
[5] K. Prasad. Modulation of the effects of tumor therapeutic agents by vitamin C. , 1980, Life sciences.
[6] M. Oren,et al. The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.
[7] G. Melino,et al. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. , 1995, European journal of cancer.
[8] C. Nicco,et al. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[10] Sam W. Lee,et al. Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions , 2003, Molecular and Cellular Biology.
[11] D. Kabelitz,et al. A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. , 1985, Journal of immunological methods.
[12] J. Verrax,et al. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. , 2009, Free radical biology & medicine.
[13] S. Rosenberg,et al. Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells. , 2008, Human gene therapy.
[14] L. Behrend,et al. Reactive oxygen species in oncogenic transformation. , 2003, Biochemical Society transactions.
[15] Olivier Soubrane,et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. , 2005, Cancer research.
[16] L. Pauling,et al. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[17] Stephen M Hewitt,et al. Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use , 2004, Annals of Internal Medicine.
[18] Kiyoko Kato,et al. Level of reactive oxygen species induced by p21WAF(1)/CIP(1) is critical for the determination of cell fate , 2009, Cancer science.
[19] J. O'fallon,et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. , 1979, The New England journal of medicine.
[20] D. S. St. Clair,et al. p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury , 2011, PloS one.
[21] P. Choyke,et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo , 2007, Proceedings of the National Academy of Sciences.
[22] D. Pearson,et al. p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours , 2008, British Journal of Cancer.
[23] K. Vousden,et al. Savior and slayer: the two faces of p53 , 2005, Nature Medicine.
[24] J. Verrax,et al. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death , 2004, Apoptosis.
[25] J. Klaunig,et al. The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.
[26] M. Krishna,et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice , 2008, Proceedings of the National Academy of Sciences.
[27] S. George,et al. An in vitro procedure for evaluation of early stage oxidative stress in an established fish cell line applied to investigation of PHAH and pesticide toxicity. , 2004, Marine environmental research.
[28] D. Coppola,et al. P53 enhances ascorbyl stearate-induced G2/M arrest of human ovarian cancer cells. , 2007, Anticancer research.
[29] W. El-Deiry,et al. Acute overexpression of wt p53 facilitates anticancer drug‐induced death of cancer and normal cells , 1998, International journal of cancer.
[30] Yong Soo Lee. Role of intracellular Ca2+ signal in the ascorbate-induced apoptosis in a human hepatoma cell line , 2004, Archives of pharmacal research.
[31] J. Ravanat,et al. Ascorbate and H2O2 induced oxidative DNA damage in Jurkat cells. , 2006, Free radical biology & medicine.
[32] W. Liu,et al. Sodium 5,6‐benzylidene‐L‐ascorbate induces oxidative stress, autophagy, and growth arrest in human colon cancer HT‐29 cells , 2010, Journal of cellular biochemistry.
[33] P. Chumakov,et al. The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.
[34] D. Housman,et al. p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.
[35] James B. Mitchell,et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Elledge,et al. Life and death by P53 , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[37] B. Liu,et al. ROS and p53: a versatile partnership. , 2008, Free radical biology & medicine.